Venclexta (venetoclax tablets) — Cigna
Acute Myeloid Leukemia (including Blastic Plasmacytoid Dendritic Cell Neoplasm)
Initial criteria
- Patient age ≥ 18 years
- Venclexta is used in combination with azacitidine OR decitabine OR cytarabine
Approval duration
1 year